Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression.
Theranostics
; 12(15): 6665-6681, 2022.
Article
in En
| MEDLINE
| ID: mdl-36185610
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Theranostics
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: